MARKET

DARE

DARE

Dare Bioscience Inc
NASDAQ
1.690
+0.010
+0.60%
After Hours: 1.740 +0.05 +2.96% 18:51 02/06 EST
OPEN
1.730
PREV CLOSE
1.680
HIGH
1.750
LOW
1.690
VOLUME
64.85K
TURNOVER
--
52 WEEK HIGH
9.19
52 WEEK LOW
1.610
MARKET CAP
24.15M
P/E (TTM)
-0.8809
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at DARE last week (0126-0130)?
Weekly Report · 5d ago
Daré Bioscience Launches Regulation A Preferred Unit Offering
TipRanks · 01/29 22:38
Weekly Report: what happened at DARE last week (0119-0123)?
Weekly Report · 01/26 10:06
After-Hours Gainers: ATOS, IBRX, FEMY, FHTX, DARE, TBPH
NASDAQ · 01/20 04:19
Weekly Report: what happened at DARE last week (0112-0116)?
Weekly Report · 01/19 10:11
Weekly Report: what happened at DARE last week (0105-0109)?
Weekly Report · 01/12 10:11
Daré Bioscience Issues Updated Investor Corporate Presentation
TipRanks · 01/06 13:34
Weekly Report: what happened at DARE last week (1229-0102)?
Weekly Report · 01/05 10:06
More
About DARE
Dare Bioscience, Inc. is a biopharmaceutical company. The Company's programs target unmet needs in women's health, primarily in the areas of contraception, sexual health, pelvic pain, fertility, infectious disease, vaginal health and menopause. Its product includes XACIATO (clindamycin phosphate) vaginal gel 2%. XACIATO is a single-dose prescription medication for the treatment of bacterial vaginosis in females 12 years of age and older. Its other product candidates include Ovaprene, Sildenafil Cream, and DARE-HRT1. Ovaprene is an investigational, hormone-free, monthly intravaginal contraceptive. Sildenafil Cream is a novel cream formulation of sildenafil for the treatment of female sexual arousal disorder; and DARE-HRT1 is an intravaginal ring designed to deliver a combination of menopausal hormone therapy, bio-identical 17b-estradiol and progesterone together, continuously over a 28-day period for the treatment of moderate to severe vasomotor symptoms, also known as hot flashes.

Webull offers Dare Bioscience Inc stock information, including NASDAQ: DARE real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, DARE stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading DARE stock methods without spending real money on the virtual paper trading platform.